Your browser doesn't support javascript.
loading
Successful bridge therapy of gilteritinib to cord blood transplantation in relapsed acute myeloid leukemia after bone marrow transplantation.
Kamitani, Iku; Saito, Takeshi; Yokoyama, Hiroki; Nakano, Aya; Ishii, Hiroto; Tanoue, Susumu; Hattori, Daiki; Oshima, Sayaka; Ishii, Shoko; Gunji, Tadahiro; Fukushima, Ryoko; Katsube, Atsushi; Shimada, Takaki; Nishiwaki, Kaichi; Dobashi, Nobuaki; Yano, Shingo.
Affiliation
  • Kamitani I; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Japan.
  • Saito T; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Japan. Electronic address: takexsaito@jikei.ac.jp.
  • Yokoyama H; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Japan.
  • Nakano A; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Japan.
  • Ishii H; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Japan.
  • Tanoue S; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Japan.
  • Hattori D; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Japan.
  • Oshima S; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Japan.
  • Ishii S; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Japan.
  • Gunji T; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Japan.
  • Fukushima R; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Japan.
  • Katsube A; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Japan.
  • Shimada T; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Japan.
  • Nishiwaki K; Division of Clinical Oncology/Hematology, The Jikei University Kashiwa Hospital, Japan.
  • Dobashi N; Division of Clinical Oncology/Hematology, The Jikei University Daisan Hospital, Japan.
  • Yano S; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Japan.
J Infect Chemother ; 27(4): 639-641, 2021 Apr.
Article in En | MEDLINE | ID: mdl-33214069
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation / Cord Blood Stem Cell Transplantation Limits: Adult / Humans / Male Language: En Journal: J Infect Chemother Journal subject: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2021 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation / Cord Blood Stem Cell Transplantation Limits: Adult / Humans / Male Language: En Journal: J Infect Chemother Journal subject: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2021 Type: Article Affiliation country: Japan